Coming up: speaking engagements & events – open invitation
Friday, 11 September 2015
Access to Medicine Index
In the coming weeks, come and join Wim Leereveld, CEO, and Jayasree K. Iyer, Head of Research, from the Access to Medicine Foundation, at a series of public events to discuss access to medicine and the role for pharmaceutical companies.
15 Sept, Dublin
Access to Medicine Seminar, Irish Forum for Global Health
We are delighted to announce that the Centre for Global Health has invited the Access to Medicine Foundation to lead a seminar on how the research-based pharmaceutical industry is addressing access to medicine in low- and middle-income countries. Wim Leereveld, CEO and Founder of the Access to Medicine Foundation, together with Jayasree K. Iyer, Head of Research, will present the Foundation’s latest findings in this area, and explore key global health topics such as maternal and child health and vaccines. They will also introduce the aims of the first Access to Vaccines Index.
When: 15 September, 5-7pm
Where: Trinity College, Dublin, Ireland
To register: send an email to email@example.com.
24 Sept, London
PharmaAfrica Market Access Conference
The annual PharmaAfrica Market Access Conference is dedicated to exploring the challenges and opportunities for Africa’s pharmaceutical market-access and patient-access landscapes. Tara Prasad, Research Programme Manager at the Access to Medicine Foundation, will be speaking in event’s the first plenary roundtable, which will address whether public-private healthcare partnerships are an effective tool for improving both market access and access-to-medicine.
When: 24 September, 2-3:30pm
Where: The Grange Hotel, London, UK
To register: via website
12 & 13 Oct, Berlin
2015 World Health Summit
Wim Leereveld will address the 2015 World Health Summit during the event’s plenary session on 13 October, hosted by the Germany Federal Ministries of Health (BMG) and of Education and Research (BMBF). The session will cover the assessment, treatment and prevention of Ebola, with Wim setting out the potential for the pharmaceutical industry to increase access to appropriate interventions.
Jay Iyer will also be speaking during the World Health Summit, in a Workshop Session on newborn mortality. Jay will set out how pharmaceutical companies are strengthening health systems in low- and middle-income countries, and making key health interventions more widely available and accessible for mothers and newborns.
When: 12 October, 9-10:30am; 13 October, 9-10:30am
Where: Federal Foreign Office, Berlin
To register: via website
16 October, Amsterdam
Annual Congress of the Netherlands Society of Tropical Medicine 2015
During its 2015 Annual Congress, the Netherlands Society of Tropical Medicine will be discussing access to quality essential medicines and the debate on achieving universal health coverage. Danny Edwards, Research Programme Manager, will speak in a join session, entitled Access is Key, on the Access to Medicine Index and the MSF Global Access Campaign.
When: 16 October, 3:15-4:30
Where: De Rode Hoed, Amsterdam
To register: via website
About the Access to Medicine Index
The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies with products for high-burden diseases in low- and middle-income countries. The Index ranks these companies according to their efforts to improve access to medicine in seven areas of corporate behaviour, including pricing, patents, ethical behaviour and donations. It covers 107 low- and middle-income countries and 50 high-burden diseases, and examines eight types of products, from medicines to vaccines to diagnostics. The Index identifies best practices, highlights where progress is being made, and uncovers where critical action is still required. In this way, the Index provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. It is published every two years by the Access to Medicine Foundation, an independent non-profit organisation.
About the Access to Medicine Foundation
The Access to Medicine Foundation is an independent, non-profit organisation based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine. The Foundation is funded by the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs and the UK Department for International Development. For ten years, the Foundation has been building consensus on the role for the pharmaceutical industry in improving access to medicine and vaccines. It published its first benchmark of industry activity in this area in 2008, in the first Access to Medicine Index. The fifth Access to Medicine Index was published in November 2016. In 2017, the Foundation will publish the first Access to Vaccines Index, funded by the Dutch National Postcode Lottery, and the first Antimicrobial Benchmark, funded by the UK and Dutch governments.